Condition: End Stage Renal Disease · Hemodialysis Access Failure · Sponsor: Merit Medical Systems, Inc.
The goal of this observational study is to increase the understanding of the safety and performance of Merit Medical's HeRO Graft System (HeRO) and Super HeRO Adaptor and Support Seal System (Super HeRO) devices. This study includes adults that are being treated with one of these devices as part of their regular medical care for maintaining long-term dialysis access when all other dialysis access options have failed. If participants in the study are not seen for a standard of care clinic visit during the 4 visit timepoints over 2 years, the participant will be followed by phone to check their current health and dialysis status.
This description comes directly from the study's public registry record.
Hannah Susmeyer · 978-758-6166 · Hannah.Susmeyer@merit.com
Vicky Brunk, RN · 717-873-3309 · Vicky.Brunk@merit.com
Always discuss trial participation with your own doctor first.
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | Recruiting |
| Sarasota Memorial Health Care System | Sarasota, Florida, United States | Recruiting |
| WakeMed | Raleigh, North Carolina, United States | Recruiting |
| University Pittsburgh Medical Center | Pittsburgh, Pennsylvania, United States | Recruiting |
| Baylor Scott & White Heart and Vascular Hospital - Dallas | Dallas, Texas, United States | Recruiting |
| Houston Methodist Hospital | Houston, Texas, United States | Recruiting |
| Sentara Norfolk General Hospital | Norfolk, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06422871